Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation

Eugenio Baraldi1, Gea Bonetto, Franco Zacchello

  • 1Department of Pediatrics, School of Medicine, University of Padova, Via Giustiniani 3, 35128 Padova, Italy. baraldi@pediatria.unipd.it

Insights

School-age survivors of bronchopulmonary dysplasia (BPD) exhibit persistent airflow limitation. Unlike asthma patients, these children show low exhaled nitric oxide (FeNO) levels and no response to beta(2)-agonists, suggesting unique airway pathology.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Neonatology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants.
  • BPD survivors may experience long-term airflow limitation and asthma-like symptoms.
  • The underlying pathological mechanisms of these respiratory issues remain unclear.

Purpose of the Study:

  • To investigate exhaled nitric oxide (FeNO) levels and lung function in school-age survivors of BPD.
  • To compare respiratory parameters in BPD survivors with healthy controls and children with asthma.

Main Methods:

  • Measured FeNO and performed lung function tests (including FEV1) in 31 school-age BPD survivors.
  • Compared results with healthy term-born controls, preterm children without BPD, and 31 children with asthma.

Main Results:

  • BPD survivors displayed airflow obstruction (mean FEV1 77.8% predicted), unresponsive to beta(2)-agonists in 72%.
  • FeNO levels in BPD survivors (7.7 ppb) were significantly lower than in healthy controls (10.7 ppb) and preterm children without BPD (9.9 ppb).
  • BPD survivors had FeNO levels four times lower than children with comparable airflow limitation due to asthma (24.9 ppb).

Conclusions:

  • School-age BPD survivors exhibit airflow limitation with low FeNO and lack of bronchodilator reversibility.
  • These findings differ from asthma and suggest airway pathology related to early-life structural changes in BPD.
  • Low FeNO may indicate distinct inflammatory or structural pathways in BPD-related chronic lung disease.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...